| |
Macular holes stage 2
|
Macular holes stage 3
|
Macular holes stage 4
|
|---|
|
Phako-PPV
|
PPV
|
P Value
|
Phako-PPV
|
PPV
|
P Value
|
Phako-PPV
|
PPV
|
P Value
|
|---|
|
Mean BCVA preoperatively in LogMAR (±SD)
|
0.60 (±0.28)
|
0.59 (±0.20)
|
0.918†
|
0.69 (±0.28)
|
0.76 (±0.26)
|
0.132†
|
0.95 (±0.47)
|
0.90 (±0.30)
|
0.800†
|
|
Mean BCVA end of follow-up in LogMAR (±SD)
|
0.39 (±0.22)
|
0.31 (±0.19)
|
0.340†
|
0.46 (±0.22)
|
0.51 (±0.33)
|
0.435†
|
0.45 (±0.17)
|
0.49 (±0.16)
|
0.597†
|
|
P Value: BCVA preoperatively vs. end of follow-up
|
<0.001‡
|
0.003‡
| |
<0.001‡
|
<0.001‡
| |
0.002‡
|
0.002‡
| |
- † One-Way Anova for between-group comparisons; ‡ two tailed paired sample t-Testfor within-group comparisons. BCVA Best corrected visual acuity, LogMAR Logarithm of the minimum angle of resolution, PPV Pars plana vitrectomy, SD Standard deviation.
